While the plaque reduction neutralization test (PRNT) is considered the gold standard for determining neutralizing antibody levels to flaviviruses, the assay is time-consuming and laborious.
Use cases · CRO & CDMO services
A group that outsources is a group that ran into the edge of its own bench.
Service work is bought at a specific moment: the study needs a capability the group does not have, or has and cannot scale. That moment is visible from outside, because the paper that precedes it says what was attempted, what was limiting, and what the authors intend to do next.
- Who?
- Jean Claude Balingit, Meng Ling Moi and colleagues, Vaccines, 2020
- What problem?
- Throughput, in their own words (highlighted).
- Why your solution?
- If you run neutralization testing as a service, you take over work they describe as time-consuming and laborious. Potential fit.
- Why reach out?
- The scope of work is in their own sentence: the gold-standard assay, and why it is hard to run at scale.
Open the paper ↗
The opening
They have already written it down.
Selling into it is therefore a reading problem rather than a volume problem. You do not need every academic group in a country. You need the ones whose stated next step is the thing you do, and the sentence in which they said it.
The language to search
The limits that turn into a statement of work, as the authors describe them:
Categories we extract and verify, not keywords we grep for. A sentence saying a feared problem did not occur is not a problem, and the verification pass is there to drop it.
Across all segments today: 14,860 researchers with a limitation in print, 30,404 verified quotes, and 18,843 researchers whose instruments and reagents we can name.
How the work goes
Three moves, in order.
Read the future-need sentence, not just the complaint
Discussion sections say what the group would do with more capacity or a different method. We extract that alongside the limitation, so you can sort by intent rather than only by frustration.
Qualify on the work, not the letterhead
Institution size tells you nothing about whether a group needs you this quarter. What they published, what they used, and what they said was limiting tells you a great deal.
Bring the funding context with you
Grants and trial registrations sit next to the publication record, so you can tell a group that has just been funded for the next phase from one that is writing up the last one.
See it on your own catalogue.
We run the search live against the researchers you sell to, and you decide from what is there.
Other segments: Reagents & antibodies · Instruments · IVD & med-tech